EVP, Technical Operations of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Michael A. Desjardin (insider trades) sold 17,043 shares of HZNP on 02/26/2021 at an average price of $92.43 a share. The total sale was $1.6 million.
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics PLC has a market cap of $20.37 billion; its shares were traded at around $90.910000 with a P/E ratio of 55.44 and P/S ratio of 8.86.
Directors and Officers Recent Trades:
- EVP, Technical Operations Michael A. Desjardin sold 17,043 shares of HZNP stock on 02/26/2021 at the average price of $92.43. The price of the stock has decreased by 1.64% since.
- EVP & President, International Vikram Karnani sold 8,358 shares of HZNP stock on 02/22/2021 at the average price of $87.19. The price of the stock has increased by 4.27% since.
- EVP, Chief Human Resources Off Irina Konstantinovsky sold 5,698 shares of HZNP stock on 02/22/2021 at the average price of $87.22. The price of the stock has increased by 4.23% since.
- EVP, Technical Operations Michael A. Desjardin sold 10,786 shares of HZNP stock on 02/11/2021 at the average price of $90. The price of the stock has increased by 1.01% since.
- EVP, Technical Operations Michael A. Desjardin sold 4,530 shares of HZNP stock on 02/02/2021 at the average price of $85. The price of the stock has increased by 6.95% since.
For the complete insider trading history of HZNP, click here
.
